Pharmacological Activation of p53 Induces Dose-Dependent Changes in Endothelial Cell Fate during Angiogenic Sprouting

Using non-genotoxic small molecule and stapled peptide compounds to pharmacologically activate p53 via MDM2 inhibition, scientists demonstrated that graded levels of p53 induce distinct cellular fates in normal endothelial cells.